Literature DB >> 24265566

Biliary peritonitis after radiofrequency ablation diagnosed by gadoxetic acid-enhanced MR imaging.

Akihiro Furuta1, Hiroyoshi Isoda, Takashi Koyama, Giro Todo, Yukio Osaki, Kaori Togashi.   

Abstract

This study describes the first case of biliary peritonitis after radiofrequency ablation diagnosed by magnetic resonance (MR) imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA), a hepatocyte-specific MR imaging contrast agent. The image acquired 300 minutes after the administration of Gd-EOB-DTPA was useful to make a definite diagnosis and to identify the pathway of bile leakage. It is important to decide on the acquisition timing with consideration of the predicted location of bile duct injury.

Entities:  

Keywords:  Biliary peritonitis; Gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid; MRI; Radiofrequency ablation

Mesh:

Substances:

Year:  2013        PMID: 24265566      PMCID: PMC3835638          DOI: 10.3348/kjr.2013.14.6.914

Source DB:  PubMed          Journal:  Korean J Radiol        ISSN: 1229-6929            Impact factor:   3.500


  10 in total

1.  Helical CT cholangiography for the detection and localization of bile duct leakage.

Authors:  H P Dinkel; R Moll; H J Gassel; J Knüpffer; W Timmermann; M Fieger; G Schindler
Journal:  AJR Am J Roentgenol       Date:  1999-09       Impact factor: 3.959

2.  Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases.

Authors:  Ryosuke Tateishi; Shuichiro Shiina; Takuma Teratani; Shuntaro Obi; Shinpei Sato; Yukihiro Koike; Tomonori Fujishima; Haruhiko Yoshida; Takao Kawabe; Masao Omata
Journal:  Cancer       Date:  2005-03-15       Impact factor: 6.860

3.  Bile duct leaks after laparoscopic cholecystectomy: value of contrast-enhanced MRCP.

Authors:  M Aduna; J A Larena; D Martín; B Martínez-Guereñu; I Aguirre; E Astigarraga
Journal:  Abdom Imaging       Date:  2005 Jul-Aug

4.  Treatment efficacy of radiofrequency ablation of 338 patients with hepatic malignant tumor and the relevant complications.

Authors:  Min-Hua Chen; Wei Yang; Kun Yan; Wen Gao; Ying Dai; Yan-Bin Wang; Xiao-Peng Zhang; Shan-Shan Yin
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

5.  Confident diagnosis of bronchobiliary fistula using contrast-enhanced magnetic resonance cholangiography.

Authors:  Nevzat Karabulut; Vefa Cakmak; Göksel Kiter
Journal:  Korean J Radiol       Date:  2010-06-21       Impact factor: 3.500

6.  Biloma formation after radiofrequency ablation of hepatocellular carcinoma: incidence, imaging features, and clinical significance.

Authors:  Il Soo Chang; Hyunchul Rhim; Seong Hyun Kim; Young-sun Kim; Dongil Choi; Yulri Park; Hyo Keun Lim
Journal:  AJR Am J Roentgenol       Date:  2010-11       Impact factor: 3.959

7.  Gadolinium-ethoxybenzyl-DTPA as a hepatobiliary contrast agent for use in MR cholangiography: results of an in vivo phase-I clinical evaluation.

Authors:  M Bollow; M Taupitz; B Hamm; T Staks; K J Wolf; H J Weinmann
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

8.  Biliary MR imaging with Gd-EOB-DTPA and its clinical applications.

Authors:  Nam Kyung Lee; Suk Kim; Jun Woo Lee; Suk Hong Lee; Dae Hwan Kang; Gwang Ha Kim; Hyung Il Seo
Journal:  Radiographics       Date:  2009-10       Impact factor: 5.333

9.  Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma.

Authors:  Frank T C Tschirch; Anja Struwe; Henrik Petrowsky; Irini Kakales; Borut Marincek; Dominik Weishaupt
Journal:  Eur Radiol       Date:  2008-03-28       Impact factor: 5.315

10.  Scintigraphic diagnosis of bile leakage after laparoscopic cholecystectomy. A prospective study.

Authors:  H L Pasmans; P M Go; D J Gouma; G A Heidendal; J M van Engelshoven; M J van Kroonenburgh
Journal:  Clin Nucl Med       Date:  1992-09       Impact factor: 7.794

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.